These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 21526280)
21. Upgrading quality assurance for pharmacy-prepared sterile products. Zellmer WA Am J Hosp Pharm; 1991 Nov; 48(11):2387-8. PubMed ID: 1746571 [No Abstract] [Full Text] [Related]
22. Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities. Weller T; Kragseth R; Dullinger R; Illum H; Perry A Int J Pharm Compd; 2015; 19(3):182-92. PubMed ID: 26714359 [TBL] [Abstract][Full Text] [Related]
23. Quality Control Testing for Tracking Endotoxin-Producing Gram-Negative Bacteria during the Preparation of Polyvalent Snake Antivenom Immunoglobulin. Sheraba NS; Diab MR; Yassin AS; Amin MA; Zedan HH PDA J Pharm Sci Technol; 2015; 69(4):499-510. PubMed ID: 26242786 [TBL] [Abstract][Full Text] [Related]
24. [Recommendations for the safety preparation of sterile medicines in medical wards]. Martín de Rosales Cabrera AM; López Cabezas C; Pernía López MS; Dávila Pousa C; Vila Clérigues MN; Alonso Herreros JM; García Salom P; Lozano Blázquez A Farm Hosp; 2014 Jan; 38(1):57-64. PubMed ID: 24483861 [TBL] [Abstract][Full Text] [Related]
25. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Claims of IKS principles]. Witschi T Pharm Acta Helv; 1973 Feb; 48(2):53-62. PubMed ID: 4706309 [No Abstract] [Full Text] [Related]
26. Continuous and Effective Microbiological Air Monitoring in Critical Environments: A Comparison of Analytical Methodologies. Dalmaso G; Campanella A; Lazzeri P PDA J Pharm Sci Technol; 2020; 74(4):446-455. PubMed ID: 32060221 [TBL] [Abstract][Full Text] [Related]
27. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding. Hyde TD Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341 [TBL] [Abstract][Full Text] [Related]
28. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators. Peters GF; McKeon MR; Weiss WT Am J Health Syst Pharm; 2007 Mar; 64(6):622-31. PubMed ID: 17353571 [TBL] [Abstract][Full Text] [Related]
29. The Medicines Act 1968--its impact on the hospital pharmacist in relation to sterile products. Sprake JM Hosp Eng; 1978 Oct; 32(8):24-7. PubMed ID: 10239209 [No Abstract] [Full Text] [Related]
30. Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding. Akers MJ Int J Pharm Compd; 2016; 20(4):307-314. PubMed ID: 28333676 [TBL] [Abstract][Full Text] [Related]
32. Drug product quality. Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595 [No Abstract] [Full Text] [Related]
33. Basics of sterile compounding: bubble point testing. Thoma L Int J Pharm Compd; 2014; 18(1):54-7. PubMed ID: 24881342 [TBL] [Abstract][Full Text] [Related]
34. Automated endotoxin testing program for high-risk-level compounded sterile preparations at an institutional compounding pharmacy. Cooper JF; Latta KS; Smith D Am J Health Syst Pharm; 2010 Feb; 67(4):280-6. PubMed ID: 20133532 [TBL] [Abstract][Full Text] [Related]
35. Design control and validation of a facility for sterile clinical trial preparations. Staines L J Parenter Sci Technol; 1984; 38(3):109-14. PubMed ID: 6747778 [No Abstract] [Full Text] [Related]
36. USP publishes enforceable chapter on sterile compounding. Thompson CA Am J Health Syst Pharm; 2003 Sep; 60(18):1814, 1817-8, 1822. PubMed ID: 14521028 [No Abstract] [Full Text] [Related]
37. Quality Assurance and Quality Control, Part 2. Akers MJ Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362 [TBL] [Abstract][Full Text] [Related]
38. Quality Control-Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding. Allen LV Int J Pharm Compd; 2018; 22(3):206-217. PubMed ID: 29878889 [TBL] [Abstract][Full Text] [Related]
39. Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2. Martin M Int J Pharm Compd; 2018; 22(6):475-478. PubMed ID: 30384348 [TBL] [Abstract][Full Text] [Related]